Amphastar Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary

Amphastar Pharmaceuticals

06/08/2026 22:40

Amphastar Pharmaceuticals, Inc. AMPH.OQ reported quarterly adjusted earnings of 91 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 85 cents.  The mean expectation of seven analysts for the quarter was for earnings of 62 cents per share. Wall Street expected results to range from 42 cents to 74 cents per share.
Revenue rose 5.4% to $183.90 million from a year ago; analysts expected $182.06 million. 
Amphastar Pharmaceuticals, Inc.'s reported EPS for the quarter was 67 cents​.
The company reported quarterly net income of $30.35 million.
Amphastar Pharmaceuticals, Inc. shares had risen by 0.3% this quarter and lost 24.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 15.2% in the last three months.​ 
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 6 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is  "buy."
Wall Street's median 12-month price target for Amphastar Pharmaceuticals, Inc. is $20.50, about 1.3% above its last closing price of $20.24
This summary was machine generated from LSEG data August 6 at 09:40 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.62
0.91
Beat
Mar. 31 2026 
0.71
0.42
Missed
Dec. 31 2025 
0.92
0.73
Missed
Sep. 30 2025 
0.82
0.93
Beat